Aim: Muscle contraction stimulates skeletal muscle glucose transport. Since it occurs inde-21 pendently of insulin, it is an important alternative pathway to increase glucose uptake in insu-22 lin-resistant states, but the intracellular signalling mechanisms are not fully understood. Muscle 23 contraction activates group I p21-activated kinases (PAKs) in mouse and human skeletal mus-24 cle. PAK1 and PAK2 are downstream targets of Rac1, which is a key regulator of contraction-25 stimulated glucose transport. Thus, PAK1 and PAK2 could be downstream effectors of Rac1 26 in contraction-stimulated glucose transport. The current study aimed to test the hypothesis that 27 PAK1 and/or PAK2 regulate contraction-induced glucose transport. Methods: Glucose 28 transport was measured in isolated soleus and extensor digitorum longus (EDL) mouse skeletal 29 muscle incubated either in the presence or absence of a pharmacological inhibitor (IPA-3) of 30 group I PAKs or originating from whole-body PAK1 knockout (KO), muscle-specific PAK2 31 (m)KO or double whole-body PAK1 and muscle-specific PAK2 knockout mice. Results: IPA-32 3 attenuated (-22%) the increase in muscle glucose transport in response to electrically-stimu-33 lated contraction. PAK1 was dispensable for contraction-stimulated glucose uptake in both so-34 leus and EDL muscle. Lack of PAK2, either alone (-13%) or in combination with PAK1 (-35 14%), reduced contraction-stimulated glucose transport compared to control littermates in 36 EDL, but not soleus muscle. Conclusion: Contraction-stimulated glucose transport in isolated 37 glycolytic mouse EDL muscle is partly dependent on PAK2, but not PAK1. 38 Keywords 39 Contraction; Glucose uptake, Metabolism; p21-activated kinase; Skeletal muscle.
Introduction
normally phosphorylated in response to contractions in both muscles (Fig. 3C+D ). Another 112 contraction-stimulated downstream target of AMPKα2, pTBC1D1 S231 was unaffected by 113 lack of PAK1 and/or PAK2 in soleus muscle (Fig. 3E ), but was reduced (-39%) in 1/m2 dKO 114 EDL muscle compared to muscle from PAK1 KO mice (Fig. 3F ). Protein expression of 115 AMPKα2, ACC and TBC1D1 was unaffected by lack of PAK1 and/or PAK2 (representative 116 blots in Fig. 2K+L ). We next analyzed the total protein content of proteins involved in glucose 117 handling. Previously, in a slightly younger cohort (10-16 weeks of age vs. 26-35 weeks of age), 118 we reported that GLUT4 protein expression was normal in soleus but mildly reduced in EDL 119 in PAK2 mKO mice compared to littermate control 22 . In contrast, GLUT4 protein expression 120 was presently reduced in 1/m2 dKO soleus muscle from soleus compared to control muscle (-121 29%; Fig. 3G ). In EDL muscle GLUT4 protein expression was unaffected by lack of PAK1 122 and/or PAK2 (Fig. 3H ). Protein expression of hexokinase II (HKII), a key enzyme converting 123 glucose to glucose-6-phosphate after uptake, was unaffected in soleus muscle (Fig. 3I ), while 124 higher (+34%) in 1/m2 dKO EDL muscle compared to PAK2 mKO muscle ( Fig. 3J ). Taken 125 together, the reduced contraction-stimulated glucose transport in 1/m2 dKO EDL muscle was 126 accompanied by impaired pTBC1D1 S237 phosphorylation (potentially decreasing glucose up-127 take) but also upregulation of HKII (potentially enhancing capacity for glucose uptake although 128 a previous study suggest that in isolated muscles, HKII overexpression is not sufficient to in-7 The present study is, to our knowledge, the first to investigate the requirement of PAK1 and 135 PAK2 in contraction-stimulated glucose transport in mouse skeletal muscle. By undertaking a 136 systematic investigation, including pharmacological as well as genetic interventions, we show 137 that contraction-stimulated glucose transport in isolated skeletal muscle partially requires 138 PAK2, but not PAK1, in glycolytic EDL muscle. 139 In the current study, IPA-3 attenuated the increase in muscle glucose transport in response to 140 electrically-stimulated contraction in both soleus and EDL muscle, whereas genetically tar-141 geted knockout revealed an effect of PAK2 in glycolytic EDL only. It is not unusual that phar-142 macological inhibition and genetically targeted mutations produce different phenotypes 25 . This 143 likely means that the effect of the IPA-3 on glucose transport in soleus is unspecific or alterna-144 tively, that the absent effect of genetic ablation of PAK1 and/or PAK2 in soleus is due to com-145 pensation by other mechanisms. It is important to stress that any possible compensatory mech-146 anisms cannot be via redundancy with PAK3, as even in 1/m2 dKO muscle, PAK3 cannot be 147 detected at the protein level 20 .
148
The limited role of group I PAKs in contraction-induced glucose transport is in accordance 149 with our recent finding that group I PAKs were largely dispensable for insulin-stimulated glu-150 cose transport in isolated mouse skeletal muscle with only a modest reduction in EDL muscles 151 lacking PAK2 22 . Thus, group I PAKs are not major essential components in the regulation of 152 muscle glucose transport. Based on recent emerging evidence, the role for group I PAKs in 153 skeletal muscle seems instead to be related to myogenesis and muscle mass regulation 20,23 .
154
Additionally, in embryonic day 18.5 diaphragm, combined genetic ablation of PAK1 and 155 PAK2 was associated with reduced acetylcholine receptor clustering at the neuromuscular 156 junction 20 suggesting defects in the neuromuscular synapses. (TBST) and 2% (w/v) skim milk or 3% (w/v) BSA protein for 15 minutes at room temperature, 232 followed by incubation overnight at 4°C with a primary antibody (Table 1) . Next, the mem- assessed with a mixed-effects model analysis in Fig. 2H+I .
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